These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21622172)

  • 1. Targeting rapid action of sex steroid receptors in breast and prostate cancers.
    Giovannelli P; Di Donato M; Giraldi T; Migliaccio A; Castoria G; Auricchio F
    Front Biosci (Landmark Ed); 2011 Jun; 16(6):2224-32. PubMed ID: 21622172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting rapid action of sex-steroid receptors in breast and prostate cancers.
    Giovannelli P; Di Donato M; Giraldi T; Migliaccio A; Castoria G; Auricchio F
    Front Biosci (Elite Ed); 2012 Jan; 4(1):453-61. PubMed ID: 22201885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.
    Rodriguez-Gonzalez A; Cyrus K; Salcius M; Kim K; Crews CM; Deshaies RJ; Sakamoto KM
    Oncogene; 2008 Dec; 27(57):7201-11. PubMed ID: 18794799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.
    Maximov PY; Abderrahman B; Curpan RF; Hawsawi YM; Fan P; Jordan VC
    Endocr Relat Cancer; 2018 Feb; 25(2):R83-R113. PubMed ID: 29162647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability.
    Ganguly S; Naik D; Muskara A; Mian OY
    Endocrinology; 2021 Jan; 162(1):. PubMed ID: 33260197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current topics and perspectives in the treatment of endocrine-related cancers.
    Iwase H
    Int J Clin Oncol; 2008 Oct; 13(5):377-9. PubMed ID: 18946746
    [No Abstract]   [Full Text] [Related]  

  • 8. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers.
    Purohit A; Foster PA
    J Endocrinol; 2012 Feb; 212(2):99-110. PubMed ID: 21859802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Breast cancer subtypes and their endocrine-metabolic basis; practical aspects].
    Bershteĭn LM; Semiglazov VF
    Vopr Onkol; 2011; 57(5):559-66. PubMed ID: 22238924
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral sensitivity to steroids revisited.
    Hampl R; Vondra K
    Physiol Res; 2017 Sep; 66(Suppl 3):S295-S303. PubMed ID: 28948813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-steroid hormones and EGF signalling in breast and prostate cancer cells: targeting the association of Src with steroid receptors.
    Auricchio F; Migliaccio A; Castoria G
    Steroids; 2008 Oct; 73(9-10):880-4. PubMed ID: 18342899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroid induced apoptosis as a rational strategy to treat anti-hormone resistant breast and prostate cancer.
    Jordan VC; Fan P; Abderrahman B; Maximov PY; Hawsawi YM; Bhattacharya P; Pokharel N
    Discov Med; 2016 May; 21(117):411-27. PubMed ID: 27355337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of hormone refractory breast and prostate cancer: An NCI workshop report.
    Mohla S; Stearns V; Sathyamoorthy N; Rosenfeld MG; Nelson P
    Cancer Biol Ther; 2009 Nov; 8(21):1975-85. PubMed ID: 19783900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer.
    De Amicis F; Chimento A; Montalto FI; Casaburi I; Sirianni R; Pezzi V
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.
    Honda S; Loher P; Shigematsu M; Palazzo JP; Suzuki R; Imoto I; Rigoutsos I; Kirino Y
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3816-25. PubMed ID: 26124144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
    Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
    Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-initiated steroid signaling action of estrogen and breast cancer.
    Song RX
    Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of steroid receptor and coregulator mutations in hormone-dependent cancers.
    Groner AC; Brown M
    J Clin Invest; 2017 Apr; 127(4):1126-1135. PubMed ID: 28368289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-dependent tumors. Overview.
    Ogata E
    Oncology; 1998 Dec; 55 Suppl 1():3-4. PubMed ID: 9935360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.